Health
Regeneron’s Antibody Combination Therapy Reduces COVID-19 Mortality Risk – BioPharm International
RECOVERY trial results have shown that Regeneron’s investigational antibody combination therapy reduces the mortality risk for…
Results of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial have shown that Regenerons investigational antibody combination therapy reduces the mortality risk for hospitalized patients with severe COVID-19 whose immune response has not started…
Continue Reading
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News24 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
General20 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz